Cargando…
Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management
Breast cancer is the most frequently diagnosed malignancy worldwide and the leading cause of cancer-related death among women. Brain metastases are a primary contributor to mortality, as they often go undetected until late stages due to their dormant nature. Moreover, the clinical management of brai...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298724/ https://www.ncbi.nlm.nih.gov/pubmed/37372340 http://dx.doi.org/10.3390/genes14061160 |
_version_ | 1785064188860694528 |
---|---|
author | Ivanova, Mariia Porta, Francesca Maria Giugliano, Federica Frascarelli, Chiara Sajjadi, Elham Venetis, Konstantinos Cursano, Giulia Mazzarol, Giovanni Guerini-Rocco, Elena Curigliano, Giuseppe Criscitiello, Carmen Fusco, Nicola |
author_facet | Ivanova, Mariia Porta, Francesca Maria Giugliano, Federica Frascarelli, Chiara Sajjadi, Elham Venetis, Konstantinos Cursano, Giulia Mazzarol, Giovanni Guerini-Rocco, Elena Curigliano, Giuseppe Criscitiello, Carmen Fusco, Nicola |
author_sort | Ivanova, Mariia |
collection | PubMed |
description | Breast cancer is the most frequently diagnosed malignancy worldwide and the leading cause of cancer-related death among women. Brain metastases are a primary contributor to mortality, as they often go undetected until late stages due to their dormant nature. Moreover, the clinical management of brain metastases is complicated by the relevant issue of blood-brain barrier penetration. The molecular pathways involved in the formation, progression, and colonization of primary breast tumors and subsequent brain metastases are diverse, posing significant hurdles due to the heterogeneous nature of breast cancer subtypes. Despite advancements in primary breast cancer treatments, the prognosis for patients with brain metastases remains poor. In this review, we aim to highlight the biological mechanisms of breast cancer brain metastases by evaluating multi-step genetic pathways and to discuss currently available and emerging treatment strategies to propose a prospective overview of the management of this complex disease. |
format | Online Article Text |
id | pubmed-10298724 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102987242023-06-28 Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management Ivanova, Mariia Porta, Francesca Maria Giugliano, Federica Frascarelli, Chiara Sajjadi, Elham Venetis, Konstantinos Cursano, Giulia Mazzarol, Giovanni Guerini-Rocco, Elena Curigliano, Giuseppe Criscitiello, Carmen Fusco, Nicola Genes (Basel) Review Breast cancer is the most frequently diagnosed malignancy worldwide and the leading cause of cancer-related death among women. Brain metastases are a primary contributor to mortality, as they often go undetected until late stages due to their dormant nature. Moreover, the clinical management of brain metastases is complicated by the relevant issue of blood-brain barrier penetration. The molecular pathways involved in the formation, progression, and colonization of primary breast tumors and subsequent brain metastases are diverse, posing significant hurdles due to the heterogeneous nature of breast cancer subtypes. Despite advancements in primary breast cancer treatments, the prognosis for patients with brain metastases remains poor. In this review, we aim to highlight the biological mechanisms of breast cancer brain metastases by evaluating multi-step genetic pathways and to discuss currently available and emerging treatment strategies to propose a prospective overview of the management of this complex disease. MDPI 2023-05-26 /pmc/articles/PMC10298724/ /pubmed/37372340 http://dx.doi.org/10.3390/genes14061160 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Ivanova, Mariia Porta, Francesca Maria Giugliano, Federica Frascarelli, Chiara Sajjadi, Elham Venetis, Konstantinos Cursano, Giulia Mazzarol, Giovanni Guerini-Rocco, Elena Curigliano, Giuseppe Criscitiello, Carmen Fusco, Nicola Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management |
title | Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management |
title_full | Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management |
title_fullStr | Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management |
title_full_unstemmed | Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management |
title_short | Breast Cancer with Brain Metastasis: Molecular Insights and Clinical Management |
title_sort | breast cancer with brain metastasis: molecular insights and clinical management |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10298724/ https://www.ncbi.nlm.nih.gov/pubmed/37372340 http://dx.doi.org/10.3390/genes14061160 |
work_keys_str_mv | AT ivanovamariia breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT portafrancescamaria breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT giuglianofederica breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT frascarellichiara breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT sajjadielham breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT venetiskonstantinos breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT cursanogiulia breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT mazzarolgiovanni breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT gueriniroccoelena breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT curiglianogiuseppe breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT criscitiellocarmen breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement AT fusconicola breastcancerwithbrainmetastasismolecularinsightsandclinicalmanagement |